Saturday 17 October 2026 Export TGTX’s income statement to Excel — free account

TG Therapeutics, Inc.

TG Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $616.3 million, up 87.3% from fiscal 2024. In the quarter to June 2026, revenue grew 70.3%, EPS fell 73.7%, free cash flow grew 427.1% and total debt rose 204.2%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

53.97 2.03 −3.63%

Follow TGTX

Alert me

Market cap: $8.6B
P/E: 17.8×
Fwd P/E: 29.4×
Dividend yield: —
F-score: 5/9
Altman Z: 6.29
Beneish M: 0.80
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	18.07	10.45	9.71	11.77	+8 more quarters Free account
P/S ratio Full definition →	9.74	6.85	6.98	9.88
P/FCF ratio Full definition →	448.02	0.00	0.00	0.00
P/Operating CF Full definition →	198.38	(268.15)	218.82	(226.92)
P/B ratio Full definition →	12.89	8.23	6.64	8.65
Price to Tangible BV Full definition →	12.91	8.24	6.65	8.66
EV/Sales Full definition →	9.98	7.18	7.15	10.09
EV/EBITDA Full definition →	58.71	33.95	36.42	54.16
EV/Operating CF Full definition →	446.57	(360.54)	(177.89)	(76.62)
EV/FCF Full definition →	459.19	(354.45)	(176.37)	(76.43)
Quick Ratio Full definition →	3.55	4.84	2.91	2.53
Current Ratio Full definition →	4.27	5.81	4.10	3.82
Net Debt/EBITDA Full definition →	8.87	6.63	2.05	3.93
Debt/Assets Full definition →	45.46%	48.74%	23.10%	23.94%
Debt/Equity Full definition →	1.23	1.28	0.38	0.40
Asset Turnover Full definition →	0.68	0.64	0.75	0.66
Operating CF/Net income Full definition →	5.05	(0.90)	0.85	(0.06)
Capex/Depreciation Full definition →	(3.29)	25.50	5.58	0.19
Interest Coverage Full definition →	1.31	4.54	7.73	4.37
Research and Development Expense of Revenue Full definition →	39.67%	21.24%	23.12%	25.28%
Selling, General and Administrative Expense of Revenue Full definition →	34.17%	45.43%	30.85%	39.19%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	11.60%	9.74%	8.13%	10.94%
Graham Net Nets Full definition →	0.01	0.03	0.05	0.03
Graham Number Full definition →	17.07	17.00	17.61	16.98
Earnings Yield Full definition →	5.53%	9.57%	10.30%	8.50%
Free Cash Flow Yield Full definition →	0.22%	(0.30%)	(0.58%)	(1.34%)
Revenue per Share Full definition →	1.70	1.42	1.33	1.11
Operating CF per Share Full definition →	0.28	(0.12)	0.14	(0.16)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.27	(0.12)	0.14	(0.16)
Cash per Share Full definition →	3.90	3.56	0.98	0.90
Shareholders Equity per Share Full definition →	4.26	4.04	4.49	4.18
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	4.26	4.04	4.49	4.18
Free Cash Flow Full definition →	38.97	(17.94)	19.59	(23.23)
Working Capital Full definition →	877.19	899.86	477.00	442.96
Capital Expenditures Full definition →	(0.29)	(0.05)	(0.07)	(0.08)
Net Current Asset Value Full definition →	110.14	141.26	215.53	181.96
EV/EBIT Full definition →	58.56	33.65	35.73	52.23
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	57.13	32.10	34.88	51.12
Other line items
Average Receivables Full definition →	316.54	291.08	217.41	190.56
Average Payables Full definition →	173.86	141.39	82.90	106.87
Average Inventory Full definition →	151.59	143.39	118.02	115.81
Average Assets Full definition →	1,171.12	1,092.76	820.47	805.52
Average Common Equity Full definition →	440.26	410.21	435.19	399.69

Show all line items

Columns are period end dates

Stockrow Weekly